Currently out of the existing stock ratings of Bill Sutherland, 126 are a BUY (89.36%), 15 are a HOLD (10.64%).

Bill Sutherland

Work Performance Price Targets & Ratings Chart

Analyst Bill Sutherland works at BENCHMARK with a stock forecast success ratio of 26.31% fulfilled within 122.52 days on average.

Bill Sutherland’s has documented 278 price targets and ratings displayed on 21 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on SEM, Select Medical Holdings at 12-Apr-2024.

Wall Street Analyst Bill Sutherland

Analyst best performing recommendations are on AUGX (AUGMEDIX).
The best stock recommendation documented was for AUGX (AUGMEDIX) at 3/31/2023. The price target of $5 was fulfilled within 88 days with a profit of $3.26 (187.36%) receiving and performance score of 21.29.

Average potential price target upside

of $19.66 (13.24%) on AMED (AMEDISYS).
of $16.28 (17.39%) on OMCL (OMNICELL).
of $14.79 (112.77%) on RCMT (RCM TECHNOLOGIES).

AMED Amedisys AUGX Augmedix CCRN Cross Country Healthcare HURN Huron Consulting Group OMCL Omnicell OTRK Ontrak PINC Premier SEM Select Medical Holdings SGRY Surgery Partners TRHC Tabula Rasa HealthCare UPH Uphealth YCBD cbdMD AMN AMN Healthcare Services LHCG LHC Group ATIP ATI Physical Therapy IONM Assure Holdings Corp QIPT Quipt Home Medical Corp HCSG Healthcare Services Group BEAT Heartbeam AGL agilon health RCMT RCM Technologies

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

John Ransom (RAYMOND JAMES)